Pharmacotherapy in a specialized endocrinology hospital: polypharmacy and risks of drug interactions on the example of a clinical case study

Abstract

Polypharmacy and its negative consequences in multimorbid elderly patients are an important public health problem. It is obvious that with an increase in the number of drugs used, the number of drug interactions and adverse reactions increases. The article presents a clinical case illustrating the need to monitor the safety of the simultaneous use of multiple drugs in the practice of an endocrinologist, including the use of modern instruments. When analyzing pharmacotherapy using a medical decision support system, drug interactions of moderate significance were identified. The rationality and correction of the drugs used were assessed taking into account the decrease in the filtration function of the kidneys. Using the Beers criteria, drugs that are not recommended for elderly people were identified. The use of modern tools to assess the rationality of pharmacotherapy in conditions of polypharmacy in the practice of an endocrinologist will help improve the effectiveness of therapy.